Regulation of Akt(ser473) phosphorylation by Choline kinase in breast carcinoma cells

[1]  V. Raman,et al.  Choline kinase down-regulation increases the effect of 5-fluorouracil in breast cancer cells. , 2007, Cancer research.

[2]  Marcin Skrzypski,et al.  Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study. , 2007, The Lancet. Oncology.

[3]  H. Degani,et al.  Phosphocholine as a biomarker of breast cancer: Molecular and biochemical studies , 2007, International journal of cancer.

[4]  N. Serkova,et al.  Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism. , 2006, Pharmacogenomics.

[5]  Q. Zeng,et al.  PRL-3 initiates tumor angiogenesis by recruiting endothelial cells in vitro and in vivo. , 2006, Cancer research.

[6]  Jie Huang,et al.  Protein Kinase Cϵ Activates Protein Kinase B/Akt via DNA-PK to Protect against Tumor Necrosis Factor-α-induced Cell Death* , 2006, Journal of Biological Chemistry.

[7]  V. Raman,et al.  RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation. , 2005, Cancer research.

[8]  Huan Yang,et al.  The Akt/PKB pathway: molecular target for cancer drug discovery , 2005, Oncogene.

[9]  S. Canevari,et al.  Alterations of choline phospholipid metabolism in ovarian tumor progression. , 2005, Cancer research.

[10]  David Gallego-Ortega,et al.  Choline kinase is a novel oncogene that potentiates RhoA-induced carcinogenesis. , 2005, Cancer research.

[11]  A. Newton,et al.  PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. , 2005, Molecular cell.

[12]  D. Guertin,et al.  Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex , 2005, Science.

[13]  D. Rawlings,et al.  Protein Kinase C βII Regulates Akt Phosphorylation on Ser-473 in a Cell Type- and Stimulus-specific Fashion*♦ , 2004, Journal of Biological Chemistry.

[14]  J. Lacal,et al.  Choline kinase inhibition induces the increase in ceramides resulting in a highly specific and selective cytotoxic antitumoral strategy as a potential mechanism of action , 2004, Oncogene.

[15]  M. Simons,et al.  Regulation of protein kinase B/Akt activity and Ser473 phosphorylation by protein kinase Cα in endothelial cells , 2004 .

[16]  Enrique Casado,et al.  PI3K/Akt signalling pathway and cancer. , 2004, Cancer treatment reviews.

[17]  J. Lacal,et al.  Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells , 2003, Oncogene.

[18]  R. Rosell,et al.  Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. , 2002, Biochemical and biophysical research communications.

[19]  R. Lenkinski,et al.  Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. , 2002, Journal of the National Cancer Institute.

[20]  B. Hemmings,et al.  Identification of a Plasma Membrane Raft-Associated PKB Ser473 Kinase Activity that Is Distinct from ILK and PDK1 , 2002, Current Biology.

[21]  Jose M. Silva,et al.  Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy , 2002, Oncogene.

[22]  A. Ramírez de Molina,et al.  Inhibition of ChoK is an efficient antitumor strategy for Harvey-, Kirsten-, and N-ras-transformed cells. , 2001, Biochemical and biophysical research communications.

[23]  P. Choy,et al.  Phosphatidylcholine metabolism in human endothelial cells: modulation by phosphocholine , 2000, Molecular and Cellular Biochemistry.

[24]  J. Woodgett,et al.  Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Williams,et al.  Immortalization and transformation are associated with specific alterations in choline metabolism. , 1996, Cancer research.

[26]  C. Kent,et al.  Early increase in choline kinase activity upon induction of the H-ras oncogene in mouse fibroblast cell lines. , 1995, Archives of biochemistry and biophysics.

[27]  L. del Peso,et al.  Generation of phosphorylcholine as an essential event in the activation of Raf‐1 and MAP‐kinases in growth factors‐induced mitogenic stimulation , 1995, Journal of cellular biochemistry.

[28]  A. Cuadrado,et al.  Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors. , 1993, Oncogene.

[29]  W. Negendank,et al.  Studies of human tumors by MRS: A review , 1992, NMR in biomedicine.

[30]  J. Lacal Diacylglycerol production in Xenopus laevis oocytes after microinjection of p21ras proteins is a consequence of activation of phosphatidylcholine metabolism , 1990, Molecular and cellular biology.

[31]  I. Macara Elevated phosphocholine concentration in ras-transformed NIH 3T3 cells arises from increased choline kinase activity, not from phosphatidylcholine breakdown , 1989, Molecular and cellular biology.

[32]  S. Aaronson,et al.  Novel source of 1,2-diacylglycerol elevated in cells transformed by Ha-ras oncogene , 1987, Nature.

[33]  David Gallego-Ortega,et al.  Choline kinase as a link connecting phospholipid metabolism and cell cycle regulation: implications in cancer therapy. , 2008, The international journal of biochemistry & cell biology.

[34]  Jie Huang,et al.  Protein kinase Cepsilon activates protein kinase B/Akt via DNA-PK to protect against tumor necrosis factor-alpha-induced cell death. , 2006, The Journal of biological chemistry.

[35]  J. Griffiths,et al.  Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models. , 2006, Cancer research.

[36]  M. Simons,et al.  Regulation of protein kinase B/Akt activity and Ser473 phosphorylation by protein kinase Calpha in endothelial cells. , 2004, Cellular signalling.

[37]  Colin B. Reese,et al.  3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase , 1997, Current Biology.